Lung maturation injections are recommended by doctors for cases of threatened miscarriage or risk of premature birth. Besides the benefit of reducing the risk of respiratory failure in newborns, lung maturation injections also have some unwanted side effects.

In many cases, pregnant women are advised by doctors to inject drugs to mature the fetus' lungs to prevent the risk of respiratory failure if there is a premature birth, reduce the rate of neonatal mortality and other diseases.

Lung maturation injections were first performed in the world in 1972. Since then, lung maturation injections have become popular, contributing significantly to reducing the risk of acute respiratory failure, death and other diseases in premature infants.

Lung maturation drugs are used in cases where pregnant women show signs of threatened premature birth or are at high risk of premature birth to avoid the risk of respiratory failure in newborns due to immature lungs. So should fetal lung maturation drugs be injected during pregnancy?

Currently, the two most commonly used lung maturation drugs for fetuses are Dexamethasone and Betamethasone. Lung maturation injections will help promote and support the completion of lung respiratory function, in cases where the fetus may have to be born earlier than expected.